Chempass Company
ChemPass was founded to develop AI technologies and software for the design of novel small organic molecules and scaffolds. ChemPass' technologies utilize synthetic artificial intelligence for template design, in silico reaction planning and evaluation, a chemistry know-how database and several other custom solutions.
%20.jpg)
Number Of Exists:
N/A
Technology:
Drug Design
Industry:
Drug Discovery
Founded Date:
2016
Investor Type:
N/A
Employee Number:
Undisclosed
Investment Stage:
N/A
Headquarters:
Budapest, Budapest, Hungary
Funding Status:
Seed